Free Trial

ADC Therapeutics (ADCT) SEC Filings & 10K Form

ADC Therapeutics logo
$2.60 -0.05 (-1.70%)
As of 09:55 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent ADC Therapeutics SEC Filings

DateFilerForm TypeView
07/10/2025
8:00 AM
ADC Therapeutics (Filer)
Form 424B3
07/09/2025
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
06/30/2025
4:28 PM
ADC Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/17/2025
4:28 PM
ADC Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
06/13/2025
5:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
8:01 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
4:12 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:13 PM
ADC Therapeutics (Issuer)
COUGHLIN TIMOTHY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:40 PM
ADC Therapeutics (Subject)
HPWH TH AG (Filed by)
Form SCHEDULE 13G/A
05/14/2025
7:14 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:14 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
9:50 AM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEFA14A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEF 14A
04/09/2025
11:07 AM
ADC Therapeutics (Filer)
Form PRE 14A
03/27/2025
2:28 PM
ADC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2025
2:34 PM
ADC Therapeutics (Filer)
Form ARS
03/27/2025
6:39 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:20 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:21 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:23 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:10 PM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G
01/13/2025
11:20 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:37 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:39 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:42 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:35 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:30 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:13 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
7:58 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/07/2024
9:44 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:54 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:35 PM
ADC Therapeutics (Filer)
Form DEF 14A
09/23/2024
3:39 PM
ADC Therapeutics (Filer)
Form DEFA14A
08/13/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ADCT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners